Heidy King-Jones
CIK 1794898 · See Remarks · last filed 2026-01-13
Heidy King-Jones is a corporate insider who has filed 13 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for SYRE, was dated Jan 13, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | See Remarks | — | $80.79 | — | $0 | 3 | 2026-01-13 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | See Remarks | — | $12.01 | — | $0 | 1 | 2023-09-05 |
| Provention Bio, Inc. (PRVB) Delisted | Chief Legal Officer | — | $24.98 | — | $0 | 8 | 2023-04-27 |
| Axcella Health Inc. (AXLA) Delisted | General Counsel, SVP Legal | — | $0.40 | — | $0 | 1 | 2019-12-20 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-13 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2025-01-17 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2023-09-05 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-27 | Provention Bio, Inc. (PRVB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-01-11 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-23 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-24 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-20 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-05 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |